Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(7):1572–1578. doi: 10.1111/j.1476-5381.1996.tb15323.x

Evidence for a discrete UTP receptor in cardiac endothelial cells.

S Yang 1, I L Buxton 1, C B Probert 1, J N Talbot 1, M E Bradley 1
PMCID: PMC1909455  PMID: 8730756

Abstract

1. We have examined the effects of various purine and pyrimidine nucleotides upon cells cultured from guinea-pig cardiac endothelium (CEC), and find the P2Y-agonist 2-methylthioadenosine triphosphate (2MeSATP) to be a potent (EC50 = 85 +/- 10.2 nM) stimulator of increase in intracellular calcium concentrations, while uridine 5'-triphosphate (UTP) and adenosine 5'-triphosphate (ATP) are less potent but equipotent with one another (EC50s = 2.1 +/- 0.3 and 1.8 +/- 0.2 microM, respectively). 2. While the P2Y receptor exhibited rapid homologous desensitization, this had no effect upon subsequent responsiveness of CEC to either ATP or UTP. Effects of maximal concentrations of ATP and UTP were not only additive, but did not cross-desensitize. Responses to UTP (but not to ATP or 2MeSATP) were blocked by treatment with pertussis toxin (PTX); all three nucleotides appeared to liberate calcium from an intracellular pool. 3. Suramin (30 microM) significantly (P < 0.05) increased the EC50 for ATP-dependent increases in intracellular calcium (5.3 +/- 2.2 microM vs. 2.0 +/- 0.9 microM in the absence of suramin), while it completely blocked the response to 2MeSATP. Suramin had no effect upon responses to UTP at concentrations of 100 microM. 4. We conclude that in addition to the P2Y and P2U subtypes of the ATP receptor, an additional receptor responsive to UTP but exhibiting no affinity for purine nucleotides is present in CEC; this "pyrimidine receptor' liberates intracellular calcium via a G-protein, and may partly mediate the contractile response to UTP in the coronary vasculature.

Full text

PDF
1572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boarder M. R., Turner J. T., Erb L., Weisman G. A. Classification of P2 purinoceptors. Not all G protein-coupled P2 purinoceptors can be classed as P2Y. Trends Pharmacol Sci. 1994 Aug;15(8):280–281. doi: 10.1016/0165-6147(94)90003-5. [DOI] [PubMed] [Google Scholar]
  2. Boyer J. L., Downes C. P., Harden T. K. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides. J Biol Chem. 1989 Jan 15;264(2):884–890. [PubMed] [Google Scholar]
  3. Brown H. A., Lazarowski E. R., Boucher R. C., Harden T. K. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells. Mol Pharmacol. 1991 Nov;40(5):648–655. [PubMed] [Google Scholar]
  4. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  5. Fry G., Parsons T., Hoak J., Sage H., Gingrich R. D., Ercolani L., Nghiem D., Czervionke R. Properties of cultured endothelium from adult human vessels. Arteriosclerosis. 1984 Jan-Feb;4(1):4–13. doi: 10.1161/01.atv.4.1.4. [DOI] [PubMed] [Google Scholar]
  6. Goetz U., Da Prada M., Pletscher A. Adenine-, guanine- and uridine-5'-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther. 1971 Jul;178(1):210–215. [PubMed] [Google Scholar]
  7. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Häussinger D., Stehle T., Gerok W. Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem. 1987 Aug 17;167(1):65–71. doi: 10.1111/j.1432-1033.1987.tb13304.x. [DOI] [PubMed] [Google Scholar]
  9. Kennedy C., Leff P. How should P2X purinoceptors be classified pharmacologically? Trends Pharmacol Sci. 1995 May;16(5):168–174. doi: 10.1016/s0165-6147(00)89010-0. [DOI] [PubMed] [Google Scholar]
  10. Keppens S. The complex interaction of ATP and UTP with isolated hepatocytes. How many receptors? Gen Pharmacol. 1993 Mar;24(2):283–289. doi: 10.1016/0306-3623(93)90304-g. [DOI] [PubMed] [Google Scholar]
  11. Lazarowski E. R., Harden T. K. Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J Biol Chem. 1994 Apr 22;269(16):11830–11836. [PubMed] [Google Scholar]
  12. Lustig K. D., Shiau A. K., Brake A. J., Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5113–5117. doi: 10.1073/pnas.90.11.5113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mannix R. J., Moatter T., Kelley K. A., Gerritsen M. E. Cellular signaling responses mediated by a novel nucleotide receptor in rabbit microvessel endothelium. Am J Physiol. 1993 Aug;265(2 Pt 2):H675–H680. doi: 10.1152/ajpheart.1993.265.2.H675. [DOI] [PubMed] [Google Scholar]
  14. Motte S., Pirotton S., Boeynaems J. M. Heterogeneity of ATP receptors in aortic endothelial cells. Involvement of P2y and P2u receptors in inositol phosphate response. Circ Res. 1993 Mar;72(3):504–510. doi: 10.1161/01.res.72.3.504. [DOI] [PubMed] [Google Scholar]
  15. Nees S., Gerbes A. L., Gerlach E., Staubesand J. Isolation, identification, and continuous culture of coronary endothelial cells from guinea pig hearts. Eur J Cell Biol. 1981 Jun;24(2):287–297. [PubMed] [Google Scholar]
  16. O'Connor S. E., Dainty I. A., Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991 Apr;12(4):137–141. doi: 10.1016/0165-6147(91)90530-6. [DOI] [PubMed] [Google Scholar]
  17. Purkiss J. R., West D., Wilkes L. C., Scott C., Yarrow P., Wilkinson G. F., Boarder M. R. Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists. Br J Pharmacol. 1994 Apr;111(4):1041–1046. doi: 10.1111/j.1476-5381.1994.tb14849.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ralevic V., Burnstock G. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res. 1991 Dec;69(6):1583–1590. doi: 10.1161/01.res.69.6.1583. [DOI] [PubMed] [Google Scholar]
  19. Seifert R., Schultz G. Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol Sci. 1989 Sep;10(9):365–369. doi: 10.1016/0165-6147(89)90009-6. [DOI] [PubMed] [Google Scholar]
  20. Sipma H., den Hertog A., Nelemans A. The phospholipase C activating P2U purinoceptor also inhibits cyclicAMP formation in DDT1 MF-2 smooth muscle cells. Eur J Pharmacol. 1994 Aug 16;268(3):431–437. doi: 10.1016/0922-4106(94)90069-8. [DOI] [PubMed] [Google Scholar]
  21. Tracey W. R., Peach M. J. Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res. 1992 Feb;70(2):234–240. doi: 10.1161/01.res.70.2.234. [DOI] [PubMed] [Google Scholar]
  22. Urquilla P. R. Prolonged contraction of isolated human and canine cerebral arteries induced by uridine 5'-triphosphate. Stroke. 1978 Mar-Apr;9(2):133–136. doi: 10.1161/01.str.9.2.133. [DOI] [PubMed] [Google Scholar]
  23. Urquilla P. R., Westfall D. P., Goto K., Fleming W. W. The effects of ouabain and alterations in potassium concentration on the sensitivity to drugs and the membrane potential of the smooth muscle of the guinea-pig and rat vas deferens. J Pharmacol Exp Ther. 1978 Nov;207(2):347–355. [PubMed] [Google Scholar]
  24. Vials A. J., Burnstock G. Effects of pyrimidines on the guinea-pig coronary vasculature. Br J Pharmacol. 1993 Nov;110(3):1091–1097. doi: 10.1111/j.1476-5381.1993.tb13926.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilkinson G. F., Purkiss J. R., Boarder M. R. Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells. Mol Pharmacol. 1994 Apr;45(4):731–736. [PubMed] [Google Scholar]
  26. Wilkinson G. F., Purkiss J. R., Boarder M. R. The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C. Br J Pharmacol. 1993 Mar;108(3):689–693. doi: 10.1111/j.1476-5381.1993.tb12862.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yang S., Cheek D. J., Westfall D. P., Buxton I. L. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res. 1994 Mar;74(3):401–407. doi: 10.1161/01.res.74.3.401. [DOI] [PubMed] [Google Scholar]
  28. von Kügelgen I., Bültmann R., Starke K. Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP. Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):198–205. doi: 10.1007/BF00166965. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES